Skin cancer is the most common form of cancer in America. Ultraviolet (UV) radiation from the sun is the main cause, though UV radiation from sunlamps and tanning beds can also lead to skin cancer. Melanoma is the most dangerous kind of skin cancer. When skin cancer is found and treated in its early stages, […]
In late March, Sanofi Pasteur Inc. and the FDA announced a newly licensed vaccination safe for use in children ages four to six. This combination vaccine will complete the diphtheria, tetanus, and pertussis (DTaP) vaccination series, as well as provide an inactivated poliovirus vaccination series.
Since April is Minority Health Month, the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (DHHS) are you coming together to promote “Prevention is Power: Taking Action for Health Equity!”
In early March, Hospira announced the recall of lot 42-120-JT of the magnesium sulfate in 5% dextrose injection, because the barcode on the bag may actually be the machine readable barcode for 1000 mL bags of heparin sodium two units per milliliter. According to the FDA, the company voluntarily issued the recall.
A mid-January directive to state survey agencies provides new details about Medicare’s expectations for pharmacy activities and compounding practices at critical access hospitals.
Teva pharmaceuticals announced in early March that – due to incompatibility between an ingredient in their Treanda (bendamustine) injection and components of some closed system transfer devices, adapters, and syringes – some may experience failure of equipment and/or contamination of the drug.
A bipartisan group of legislators in the House of Representatives reintroduced a bill to allow Medicare to cover state authorized pharmacist services. The bill, known as the Pharmacy in Medically Underserved Areas Enhancement Act, makes the same changes to the Social Security Act proposed by HR 4190, first introduced last year. The text of the […]
The National Governors Association (NGA) recently released a report to encourage states that are looking to increase their primary care capacity to change legislation to allow pharmacists from doing work they are qualified to do. The report identifies several barriers including “restrictive laws and regulations governing collaborative practice agreements,” a “lack of provider recognition in […]
